We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Mutated Gene Biomarker Identified for Rare Adrenal Tumors

By LabMedica International staff writers
Posted on 03 Feb 2015
Print article
The Qubit 3.0 Fluorometer
The Qubit 3.0 Fluorometer (Photo courtesy of Thermo Fisher (Life Technologies))
A mutation in a gene has been found that may serve as a biomarker for the rare adrenal tumors pheochromocytomas and paragangliomas that become malignant.

Pheochromocytomas and paragangliomas (PCC/PGL) are tumors of the autonomic nervous system arising from the adrenal medulla and extra-adrenal ganglia, respectively. PCC/PGL are more commonly associated with inherited susceptibility gene mutations than any other solid tumor.

Scientists at the Perelman School of Medicine (Philadelphia, PA, USA) used a set of 21 PCC/PGL that were selected to represent clinically benign and clinically aggressive tumors. Fresh-frozen PCC/PGL were sectioned and stained with hematoxylin and eosin to ensure sections of over 70% tumors are used for DNA extraction. Germline DNA from blood or saliva was extracted using standard protocols in the laboratory.

All DNA was quantitated with a Qubit fluorometer (Life Technologies; Carlsbad, CA, USA). To ensure high-quality genomic DNA, the A260/280 ratio was measured on a Nanodrop (Wilmington, DE, USA) and DNA was run on a 1% agarose gel. Whole-exome sequencing was performed on fresh-frozen tumor and matched germline DNA and DNA quality and fragment size were measured with an Agilent 2100 Bioanalyzer (Santa Clara, CA, USA) and concentration measured with a Qubit fluorometer.

The team reported that somatic alpha thalassemia/mental retardation syndrome X-linked (ATRX) mutations were identified in two of seven succinate dehydrogenase complex, subunit B, iron sulfur (SDHB)-associated tumors. To determine the frequency of somatic ATRX mutations in PCC/PGL, the team sequenced the ATRX coding region in a separate set of 103 tumors samples. They found that 13% of tumors had ATRX mutations.

The authors concluded that although the sample set of PCC/PGL with ATRX variants is too small to identify statistically significant associations, many had clinically aggressive features, inherited succinate dehydrogenase (SDHx) mutations and alternative lengthening of telomeres (ALT), suggesting an interaction between the somatic and inherited genomes in solid cancers, which needs to be investigated further. The study was published on January 21, 2015, in the journal Nature Communications.

Related Links:

Perelman School of Medicine
Life Technologies
Nanodrop 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.